Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Priyanka Raheja: Sharing the Final Analysis From the Roctavian Phase 1/2 Study
Priyanka Raheja/LinkedIn
Apr 18, 2026, 18:25

Priyanka Raheja: Sharing the Final Analysis From the Roctavian Phase 1/2 Study

Priyanka Raheja, Director at The Royal London Hospital Haemophilia Comprehensive Care Centre, shared EAHAD’s post on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia Journal, adding:

“Sharing the final analysis from the Roctavian phase 1/2 study.

Despite the sad news of market withdrawal, the long term follow up of the first people who participated in this trial continues to provide important learnings.”

European Association for Haemophilia and Allied Disorders (EAHAD) shared a post on LinkedIn:

“Check the article recently published on our official journal on ‘Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A’.

Take a closer look at the data on the Haemophilia Journal.”

Title: Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A

Authors: Priyanka Raheja, Savita Rangarajan, Will Lester, Bella Madan, Glenn F. Pierce, Emily Symington, Carolyn Millar, Dane Osmond, Mingjin Li, Konstantia-Maria Chavele

Priyanka Raheja

Stay updated on all scientific advances with Hemostasis Today.

Bella Madan Blood Carolyn Millar Dane Osmond EAHAD Emily Symington Glenn F. Pierce haemophilia A Haemophilia journal Health Hematology Hemophilia Hemostasis Hemostasis News Hemostasis Today Konstantia-Maria Chavele Medicine Mingjin Li Priyanka Raheja Roctavian Savita Rangarajan Valoctocogene Roxaparvovec WFH Will Lester
NewsFeed